StreetAlpha.app
Home › Stocks › AMRX

Amneal Pharmaceuticals, Inc. (AMRX)

Healthcare
$21.12
▼ −1.26%
LAST CLOSE · NOV 20

Amneal makes and sells generic, specialty and injectable medicines and distributes pharmaceuticals to government and retail buyers. It last closed at $21.12 on Nov 20, down 1.26% on the day. The next earnings report for AMRX is expected around Tue, Jan 12, 2027. For the quarter ended Sep 2026, AMRX reported EPS of -$0.06 on revenue of $862.7M, with revenue up 10.0% from a year ago. Over its last 8 reports the stock moved an average of 2.3% the session after earnings. Over the last 12 months AMRX insiders bought $0 of stock on the open market and sold $7.7M, according to SEC Form 4 filings.

AI Auto Pilots
Is AMRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AMRX.

Key Stats

Last 12 months
Results
Revenue
$3.2B
+8.9% vs a year ago
Net income
$133.3M
+2159.3% vs a year ago
EPS (diluted)
$0.40
+3900.0% vs a year ago
Free cash flow
$88.2M
2.8% margin
Valuation
Market cap
$7.4B
348.4M shares
P/E
52.8
Price over 12 month EPS
Price to sales
2.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$157.4M
At Sep 30
Debt
$2.9B
At Sep 30
Shareholder equity
$531.3M
Shares outstanding
348.4M
At Oct 30
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $2.1B$2.1BFY2021FY2022: $2.2B$2.2BFY2022FY2023: $2.4B$2.4BFY2023FY2024: $2.8B$2.8BFY2024FY2025: $3.0B$3.0BFY2025

From AMRX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Jan 12
Estimated date · Time not announced
Reported EPS
-$0.06
Quarter ended Sep 2026
Year ago EPS
$0.01
−700.0% on a GAAP basis
Revenue
$862.7M
+10.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.10Dec '24Mar 2025: $0.04Mar '25Jun 2025: $0.07Jun '25Sep 2025: $0.01Sep '25Dec 2025: $0.11Dec '25Mar 2026: $0.19Mar '26Jun 2026: $0.18Jun '26Sep 2026: -$0.06Sep '26Latest -$0.06
Revenue by quarter
Dec 2024: $730.5MDec '24Mar 2025: $695.4MMar '25Jun 2025: $724.5MJun '25Sep 2025: $784.5MSep '25Dec 2025: $814.3MDec '25Mar 2026: $722.5MMar '26Jun 2026: $796.2MJun '26Sep 2026: $862.7MSep '26Latest $862.7M
How AMRX moved after its last 8 reports
Average move the session after a report ±2.3%
Nov 3, 2026Time not announced−1.1%
Jul 30, 2026Time not announced−3.1%
Apr 22, 2026Time not announced−1.5%
Feb 27, 2026Time not announced−4.7%
Jan 13, 2026Time not announced−0.1%
Oct 30, 2025Time not announced−4.1%
Jul 21, 2025Time not announced−0.8%
May 2, 2025Time not announced+3.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on AMRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on AMRX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on AMRX

Technical Analysis

AMRX · as of the Nov 20 close · updated each morning
Uptrend

The stock is 0% above its 20 day and 5% above its 50 day average. It is 23% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 54). The nearest support is the 20 day average at $21.04, and the nearest resistance the swing high (Sep 21) at $21.18.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 3.6%/day
Key levels
$22.1252 week high+4.7%
$21.53Pivot R1+1.9%
$21.30Pivot+0.9%
$21.18Swing high (Sep 21)+0.3%
$21.12Last close
$21.0420 day average−0.4%
$20.89Pivot S1−1.1%
$20.75Swing low (Nov 17)−1.8%
$20.1350 day average−4.7%
$18.94100 day average−10.3%
$16.28200 day average−22.9%
$11.4552 week low−45.8%
Indicators
RSI (14)53.67Middle of its rangeNeutral
MACD0.39Below its signal lineBearish
Stochastic78.7Middle of its rangeNeutral
ADX (14)14.3No clear trend
Williams %R-32.3Oversold below −80, overbought above −20Neutral
CCI (20)34.7Oversold below −100, overbought above 100Neutral
Rate of change+4.9%Change over 10 sessionsBullish
ATR (14)$0.77Typical daily range, 3.6% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for AMRX

What happened before

See how AMRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow AMRX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How AMRX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for AMRXHow many large options trades hit AMRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

AMRX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲192 buying vs 129 selling
  • ●Held by funds +0.3 pts
  • ▲Funds holding +27
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding336309+8.7%
In funds' top 1057−28.6%
Held by funds48.6%48.3%+0.3 pts
New / increased61 / 13143 / 137+6.7%
Reduced / sold out96 / 3383 / 52−4.4%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See AMRX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AMRX Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$7.7M4 sales · 4 insiders
2026-05 sold $451K2026-08 sold $7.2MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 13John KielyDirectorSale50,000$17.64$882K
Aug 12Jason B. DalyEVP, Chief Legal OfficerSale216,613$17.41$3.8M
Aug 12Nikita ShahExecutive Vice PresidentSale146,403$17.51$2.6M
May 11Deborah M. AutorDirectorSale34,819$12.94$451K
Nov 17, 2025Ted C NarkDirectorSale50,000$11.72$586K
Nov 12, 2025Nikita ShahExecutive Vice PresidentSale131,856$11.92$1.6M
Every insider buy and sale for AMRX over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See AMRX insider trades →

From SEC Form 4 filings by AMRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AMRX is in one of them and how their past AMRX trades turned out.

AMRX in the AI portfolios
Loading…

AMRX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AMRX in an article yet. Here's the latest on the wider market.

AMRX in the news

AMRX Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Jun 18
Who traded AMRX · since 2019
Latest 2 filings
$1K – $15KTraded May 29, 2019Filed Jun 18, 2019
$1K – $15KTraded May 24, 2019Filed Jun 15, 2019
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CASell$1K – $15KMay 29, 2019Jun 18, 201920 d
Josh GottheimerD · NJSell$1K – $15KMay 24, 2019Jun 15, 201922 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Amneal Pharmaceuticals

Amneal develops, makes, markets and distributes medicines through three business areas. Its Affordable Medicines segment offers retail generic drugs, injectable products and biosimilars, while its Specialty segment sells branded drugs mainly for central nervous system and endocrine disorders. Its AvKARE unit distributes pharmaceuticals and other products to the U.S. federal government, retail customers and institutional buyers. The company operates mainly in the United States, India and Ireland.